12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Myog
|
ENSMUSG00000026459.4 | myogenin |
Tcf12
|
ENSMUSG00000032228.10 | transcription factor 12 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tcf12 | mm10_v2_chr9_-_72111827_72111895 | 0.99 | 2.7e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_109459843 | 8.02 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr15_-_78773452 | 7.97 |
ENSMUST00000018313.5
|
Mfng
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr9_-_22052021 | 6.07 |
ENSMUST00000003501.7
|
Elavl3
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) |
chr5_-_135251209 | 5.85 |
ENSMUST00000062572.2
|
Fzd9
|
frizzled homolog 9 (Drosophila) |
chr16_+_87553313 | 4.22 |
ENSMUST00000026700.7
|
Map3k7cl
|
Map3k7 C-terminal like |
chrX_+_48108912 | 4.11 |
ENSMUST00000114998.1
ENSMUST00000115000.3 |
Xpnpep2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
chr4_-_43523746 | 3.75 |
ENSMUST00000150592.1
|
Tpm2
|
tropomyosin 2, beta |
chr9_+_107935876 | 3.58 |
ENSMUST00000035700.8
|
Camkv
|
CaM kinase-like vesicle-associated |
chr16_+_7069825 | 3.45 |
ENSMUST00000056416.7
|
Rbfox1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr4_-_43523388 | 3.34 |
ENSMUST00000107913.3
ENSMUST00000030184.5 |
Tpm2
|
tropomyosin 2, beta |
chr5_+_105415738 | 3.07 |
ENSMUST00000112707.1
|
Lrrc8b
|
leucine rich repeat containing 8 family, member B |
chrX_+_48519245 | 2.97 |
ENSMUST00000033430.2
|
Rab33a
|
RAB33A, member of RAS oncogene family |
chr12_+_81026800 | 2.96 |
ENSMUST00000110347.2
ENSMUST00000021564.4 ENSMUST00000129362.1 |
Smoc1
|
SPARC related modular calcium binding 1 |
chr16_+_65815508 | 2.92 |
ENSMUST00000168064.1
|
Vgll3
|
vestigial like 3 (Drosophila) |
chr18_-_42899294 | 2.87 |
ENSMUST00000117687.1
|
Ppp2r2b
|
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform |
chr19_+_6105774 | 2.82 |
ENSMUST00000044451.3
|
Naaladl1
|
N-acetylated alpha-linked acidic dipeptidase-like 1 |
chr10_+_63100156 | 2.81 |
ENSMUST00000044059.3
|
Atoh7
|
atonal homolog 7 (Drosophila) |
chr4_-_82885148 | 2.80 |
ENSMUST00000048430.3
|
Cer1
|
cerberus 1 homolog (Xenopus laevis) |
chr8_-_4217133 | 2.79 |
ENSMUST00000175906.1
|
BC068157
|
cDNA sequence BC068157 |
chr18_-_42899470 | 2.77 |
ENSMUST00000120632.1
|
Ppp2r2b
|
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform |
chr9_+_30942541 | 2.47 |
ENSMUST00000068135.6
|
Adamts8
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8 |
chr8_-_4217261 | 2.43 |
ENSMUST00000168386.2
|
BC068157
|
cDNA sequence BC068157 |
chr5_-_107687990 | 2.39 |
ENSMUST00000180428.1
|
Gm26692
|
predicted gene, 26692 |
chr15_+_62178175 | 2.32 |
ENSMUST00000182476.1
|
Pvt1
|
plasmacytoma variant translocation 1 |
chr7_+_16875302 | 2.29 |
ENSMUST00000108493.1
|
Dact3
|
dapper homolog 3, antagonist of beta-catenin (xenopus) |
chr2_+_91945703 | 2.28 |
ENSMUST00000178895.1
|
Gm9821
|
predicted gene 9821 |
chr8_-_4216912 | 2.25 |
ENSMUST00000177491.1
|
BC068157
|
cDNA sequence BC068157 |
chr1_-_38664947 | 2.22 |
ENSMUST00000039827.7
ENSMUST00000027250.7 |
Aff3
|
AF4/FMR2 family, member 3 |
chr2_-_122611238 | 2.19 |
ENSMUST00000028624.8
|
Gatm
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr14_+_62292475 | 2.19 |
ENSMUST00000166879.1
|
Rnaseh2b
|
ribonuclease H2, subunit B |
chr4_-_43523595 | 2.19 |
ENSMUST00000107914.3
|
Tpm2
|
tropomyosin 2, beta |
chr2_-_110362985 | 2.19 |
ENSMUST00000099626.3
|
Fibin
|
fin bud initiation factor homolog (zebrafish) |
chr6_-_77979515 | 2.15 |
ENSMUST00000159626.1
ENSMUST00000075340.5 ENSMUST00000162273.1 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr9_-_48911067 | 2.14 |
ENSMUST00000003826.7
|
Htr3a
|
5-hydroxytryptamine (serotonin) receptor 3A |
chr1_-_74749221 | 2.07 |
ENSMUST00000081636.6
|
Prkag3
|
protein kinase, AMP-activated, gamma 3 non-catatlytic subunit |
chr7_+_28756138 | 2.05 |
ENSMUST00000178767.1
|
Gm6537
|
predicted gene 6537 |
chr1_+_87327044 | 2.01 |
ENSMUST00000173173.1
|
Gigyf2
|
GRB10 interacting GYF protein 2 |
chr10_-_7212222 | 2.00 |
ENSMUST00000015346.5
|
Cnksr3
|
Cnksr family member 3 |
chr2_+_119047116 | 1.99 |
ENSMUST00000152380.1
ENSMUST00000099542.2 |
Casc5
|
cancer susceptibility candidate 5 |
chr3_-_152266320 | 1.99 |
ENSMUST00000046045.8
|
Nexn
|
nexilin |
chr4_+_134468320 | 1.97 |
ENSMUST00000030636.4
ENSMUST00000127279.1 ENSMUST00000105867.1 |
Stmn1
|
stathmin 1 |
chr10_-_75860250 | 1.97 |
ENSMUST00000038169.6
|
Mif
|
macrophage migration inhibitory factor |
chrX_-_72656135 | 1.96 |
ENSMUST00000055966.6
|
Gabra3
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
chr8_+_95352258 | 1.94 |
ENSMUST00000034243.5
|
Mmp15
|
matrix metallopeptidase 15 |
chr18_+_60925612 | 1.92 |
ENSMUST00000102888.3
ENSMUST00000025519.4 |
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr11_-_70015346 | 1.87 |
ENSMUST00000018718.7
ENSMUST00000102574.3 |
Acadvl
|
acyl-Coenzyme A dehydrogenase, very long chain |
chr3_-_27153861 | 1.85 |
ENSMUST00000108300.1
ENSMUST00000108298.2 |
Ect2
|
ect2 oncogene |
chr8_-_4217459 | 1.85 |
ENSMUST00000176227.1
|
BC068157
|
cDNA sequence BC068157 |
chr8_-_13254154 | 1.84 |
ENSMUST00000033825.4
|
Adprhl1
|
ADP-ribosylhydrolase like 1 |
chr1_-_183147461 | 1.84 |
ENSMUST00000171366.1
|
Disp1
|
dispatched homolog 1 (Drosophila) |
chr5_-_49524764 | 1.83 |
ENSMUST00000172363.2
|
Kcnip4
|
Kv channel interacting protein 4 |
chr9_-_31913462 | 1.83 |
ENSMUST00000116615.3
|
Barx2
|
BarH-like homeobox 2 |
chr19_+_38097065 | 1.78 |
ENSMUST00000067098.6
|
Ffar4
|
free fatty acid receptor 4 |
chr10_-_128891674 | 1.77 |
ENSMUST00000026408.6
|
Gdf11
|
growth differentiation factor 11 |
chr1_+_158362261 | 1.76 |
ENSMUST00000046110.9
|
Astn1
|
astrotactin 1 |
chr8_-_125898291 | 1.75 |
ENSMUST00000047239.6
|
Pcnxl2
|
pecanex-like 2 (Drosophila) |
chr18_+_4993795 | 1.75 |
ENSMUST00000153016.1
|
Svil
|
supervillin |
chr7_+_141475459 | 1.75 |
ENSMUST00000138092.1
ENSMUST00000146305.1 |
Tspan4
|
tetraspanin 4 |
chr8_+_31091593 | 1.74 |
ENSMUST00000161713.1
|
Dusp26
|
dual specificity phosphatase 26 (putative) |
chr3_-_27153844 | 1.72 |
ENSMUST00000176242.2
ENSMUST00000176780.1 |
Ect2
|
ect2 oncogene |
chr11_-_118909487 | 1.71 |
ENSMUST00000117731.1
ENSMUST00000106278.2 ENSMUST00000120061.1 ENSMUST00000017576.4 |
Rbfox3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
chr9_+_44066993 | 1.70 |
ENSMUST00000034508.7
|
Usp2
|
ubiquitin specific peptidase 2 |
chr1_+_72824482 | 1.70 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr11_-_61453992 | 1.69 |
ENSMUST00000060255.7
ENSMUST00000054927.7 ENSMUST00000102661.3 |
Rnf112
|
ring finger protein 112 |
chr7_-_141429351 | 1.68 |
ENSMUST00000164387.1
ENSMUST00000137488.1 ENSMUST00000084436.3 |
Cend1
|
cell cycle exit and neuronal differentiation 1 |
chr7_+_28180272 | 1.67 |
ENSMUST00000173223.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr8_-_13254068 | 1.65 |
ENSMUST00000168498.1
|
Adprhl1
|
ADP-ribosylhydrolase like 1 |
chr7_+_141475240 | 1.64 |
ENSMUST00000026585.7
|
Tspan4
|
tetraspanin 4 |
chr5_+_64160207 | 1.64 |
ENSMUST00000101195.2
|
Tbc1d1
|
TBC1 domain family, member 1 |
chr14_+_45219993 | 1.64 |
ENSMUST00000146150.1
|
Gpr137c
|
G protein-coupled receptor 137C |
chr4_-_91399984 | 1.62 |
ENSMUST00000102799.3
|
Elavl2
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
chr3_-_88772578 | 1.61 |
ENSMUST00000090945.4
|
Syt11
|
synaptotagmin XI |
chr17_-_34627148 | 1.60 |
ENSMUST00000171376.1
ENSMUST00000169287.1 |
Ppt2
|
palmitoyl-protein thioesterase 2 |
chr14_-_62292959 | 1.59 |
ENSMUST00000063169.8
|
Dleu7
|
deleted in lymphocytic leukemia, 7 |
chr6_+_118066356 | 1.59 |
ENSMUST00000164960.1
|
Rasgef1a
|
RasGEF domain family, member 1A |
chr6_-_77979652 | 1.59 |
ENSMUST00000161846.1
ENSMUST00000160894.1 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr13_+_46418266 | 1.59 |
ENSMUST00000037923.3
|
Rbm24
|
RNA binding motif protein 24 |
chr2_-_32312162 | 1.58 |
ENSMUST00000155269.1
|
Dnm1
|
dynamin 1 |
chr15_-_98807910 | 1.58 |
ENSMUST00000075444.6
|
Ddn
|
dendrin |
chr2_+_119047129 | 1.57 |
ENSMUST00000153300.1
ENSMUST00000028799.5 |
Casc5
|
cancer susceptibility candidate 5 |
chr14_-_55116935 | 1.57 |
ENSMUST00000022819.5
|
Jph4
|
junctophilin 4 |
chr2_+_130277157 | 1.57 |
ENSMUST00000028890.8
ENSMUST00000159373.1 |
Nop56
|
NOP56 ribonucleoprotein |
chr16_+_57353093 | 1.56 |
ENSMUST00000159816.1
|
Filip1l
|
filamin A interacting protein 1-like |
chr13_+_16011851 | 1.55 |
ENSMUST00000042603.6
|
Inhba
|
inhibin beta-A |
chr11_+_104577281 | 1.54 |
ENSMUST00000106956.3
|
Myl4
|
myosin, light polypeptide 4 |
chr17_-_45686120 | 1.54 |
ENSMUST00000143907.1
ENSMUST00000127065.1 |
Tmem63b
|
transmembrane protein 63b |
chr7_-_25005895 | 1.53 |
ENSMUST00000102858.3
ENSMUST00000080882.6 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr3_-_27153782 | 1.53 |
ENSMUST00000175857.1
ENSMUST00000177055.1 ENSMUST00000176535.1 |
Ect2
|
ect2 oncogene |
chr7_+_127800844 | 1.52 |
ENSMUST00000106271.1
ENSMUST00000138432.1 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr17_-_45686214 | 1.50 |
ENSMUST00000113523.2
|
Tmem63b
|
transmembrane protein 63b |
chr4_+_11156411 | 1.50 |
ENSMUST00000029865.3
|
Trp53inp1
|
transformation related protein 53 inducible nuclear protein 1 |
chr4_+_45184815 | 1.50 |
ENSMUST00000134280.1
ENSMUST00000044773.5 |
Frmpd1
|
FERM and PDZ domain containing 1 |
chr3_-_108402589 | 1.48 |
ENSMUST00000147565.1
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) |
chr4_+_129287614 | 1.47 |
ENSMUST00000102599.3
|
Sync
|
syncoilin |
chr2_+_25288135 | 1.46 |
ENSMUST00000028340.3
|
Tmem210
|
transmembrane protein 210 |
chr14_+_4334763 | 1.45 |
ENSMUST00000165466.1
|
2610042L04Rik
|
RIKEN cDNA 2610042L04 gene |
chr17_-_46890405 | 1.44 |
ENSMUST00000086675.3
|
A330017A19Rik
|
RIKEN cDNA A330017A19 gene |
chr1_+_87327008 | 1.44 |
ENSMUST00000172794.1
ENSMUST00000164992.2 |
Gigyf2
|
GRB10 interacting GYF protein 2 |
chr1_+_172481788 | 1.44 |
ENSMUST00000127052.1
|
Igsf9
|
immunoglobulin superfamily, member 9 |
chr11_-_84916338 | 1.43 |
ENSMUST00000103195.4
|
Znhit3
|
zinc finger, HIT type 3 |
chr3_+_94413244 | 1.43 |
ENSMUST00000166032.1
ENSMUST00000045245.5 |
Tdrkh
|
tudor and KH domain containing protein |
chr1_+_55406163 | 1.43 |
ENSMUST00000042986.8
|
Plcl1
|
phospholipase C-like 1 |
chr5_+_123749696 | 1.39 |
ENSMUST00000031366.7
|
Kntc1
|
kinetochore associated 1 |
chr1_+_172482199 | 1.37 |
ENSMUST00000135267.1
ENSMUST00000052629.6 ENSMUST00000111235.2 |
Igsf9
|
immunoglobulin superfamily, member 9 |
chr15_-_55090422 | 1.37 |
ENSMUST00000110231.1
ENSMUST00000023059.6 |
Dscc1
|
defective in sister chromatid cohesion 1 homolog (S. cerevisiae) |
chr11_+_32000452 | 1.35 |
ENSMUST00000020537.2
ENSMUST00000109409.1 |
Nsg2
|
neuron specific gene family member 2 |
chr5_-_90640464 | 1.35 |
ENSMUST00000031317.6
|
Rassf6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr2_+_25289899 | 1.35 |
ENSMUST00000028337.6
|
Lrrc26
|
leucine rich repeat containing 26 |
chr17_-_46487641 | 1.34 |
ENSMUST00000047034.8
|
Ttbk1
|
tau tubulin kinase 1 |
chr8_+_123117354 | 1.34 |
ENSMUST00000037900.8
|
Cpne7
|
copine VII |
chr10_+_81257277 | 1.33 |
ENSMUST00000117488.1
ENSMUST00000105328.3 ENSMUST00000121205.1 |
Matk
|
megakaryocyte-associated tyrosine kinase |
chr4_+_133240778 | 1.33 |
ENSMUST00000030677.6
|
Map3k6
|
mitogen-activated protein kinase kinase kinase 6 |
chr15_+_103503261 | 1.33 |
ENSMUST00000023132.3
|
Pde1b
|
phosphodiesterase 1B, Ca2+-calmodulin dependent |
chr4_-_133872997 | 1.33 |
ENSMUST00000137486.2
|
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr7_+_28180226 | 1.32 |
ENSMUST00000172467.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr17_+_56303321 | 1.32 |
ENSMUST00000001258.8
|
Uhrf1
|
ubiquitin-like, containing PHD and RING finger domains, 1 |
chr4_+_104913456 | 1.32 |
ENSMUST00000106803.2
ENSMUST00000106804.1 |
1700024P16Rik
|
RIKEN cDNA 1700024P16 gene |
chr12_-_91779129 | 1.31 |
ENSMUST00000170077.1
|
Ston2
|
stonin 2 |
chr8_-_31918203 | 1.31 |
ENSMUST00000073884.4
|
Nrg1
|
neuregulin 1 |
chr5_-_49524809 | 1.30 |
ENSMUST00000087395.4
|
Kcnip4
|
Kv channel interacting protein 4 |
chr6_+_14901344 | 1.29 |
ENSMUST00000115477.1
|
Foxp2
|
forkhead box P2 |
chr14_+_3412614 | 1.29 |
ENSMUST00000170123.1
|
Gm10409
|
predicted gene 10409 |
chr13_+_19623163 | 1.28 |
ENSMUST00000002883.5
|
Sfrp4
|
secreted frizzled-related protein 4 |
chr2_-_132029845 | 1.27 |
ENSMUST00000028814.8
|
Rassf2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr14_-_20496780 | 1.24 |
ENSMUST00000022353.3
|
Mss51
|
MSS51 mitochondrial translational activator |
chr7_-_28302238 | 1.23 |
ENSMUST00000108315.3
|
Dll3
|
delta-like 3 (Drosophila) |
chr4_-_91376433 | 1.23 |
ENSMUST00000107109.2
ENSMUST00000107111.2 ENSMUST00000107120.1 |
Elavl2
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
chrX_+_139800795 | 1.21 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr2_-_25319095 | 1.21 |
ENSMUST00000114318.3
ENSMUST00000114310.3 ENSMUST00000114308.3 ENSMUST00000114317.3 ENSMUST00000028335.6 ENSMUST00000114314.3 ENSMUST00000114307.1 |
Grin1
|
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
chr5_-_138171248 | 1.20 |
ENSMUST00000153867.1
|
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chr19_-_45560508 | 1.20 |
ENSMUST00000026239.6
|
Poll
|
polymerase (DNA directed), lambda |
chr8_-_73353477 | 1.20 |
ENSMUST00000119826.1
|
Large
|
like-glycosyltransferase |
chr1_+_172312367 | 1.20 |
ENSMUST00000039506.9
|
Igsf8
|
immunoglobulin superfamily, member 8 |
chr5_-_72581084 | 1.19 |
ENSMUST00000073528.2
|
Zar1
|
zygote arrest 1 |
chr12_-_112929415 | 1.19 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr12_-_34528844 | 1.18 |
ENSMUST00000110819.2
|
Hdac9
|
histone deacetylase 9 |
chr14_+_3049285 | 1.18 |
ENSMUST00000166494.1
|
Gm2897
|
predicted gene 2897 |
chr2_+_163506808 | 1.17 |
ENSMUST00000143911.1
|
Hnf4a
|
hepatic nuclear factor 4, alpha |
chr7_-_141429433 | 1.17 |
ENSMUST00000124444.1
|
Cend1
|
cell cycle exit and neuronal differentiation 1 |
chr7_+_45639964 | 1.16 |
ENSMUST00000148532.1
|
Mamstr
|
MEF2 activating motif and SAP domain containing transcriptional regulator |
chr1_+_158362330 | 1.15 |
ENSMUST00000170718.1
|
Astn1
|
astrotactin 1 |
chr19_+_4154606 | 1.15 |
ENSMUST00000061086.8
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr2_+_31759993 | 1.14 |
ENSMUST00000124089.1
|
Abl1
|
c-abl oncogene 1, non-receptor tyrosine kinase |
chr2_+_32363680 | 1.14 |
ENSMUST00000113331.1
ENSMUST00000113338.2 |
Ciz1
|
CDKN1A interacting zinc finger protein 1 |
chr8_-_84937347 | 1.13 |
ENSMUST00000109741.2
ENSMUST00000119820.1 |
Mast1
|
microtubule associated serine/threonine kinase 1 |
chr17_+_84511832 | 1.13 |
ENSMUST00000047206.5
|
Plekhh2
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 |
chrX_+_134404543 | 1.13 |
ENSMUST00000113228.1
ENSMUST00000153424.1 |
Drp2
|
dystrophin related protein 2 |
chr8_-_13254096 | 1.13 |
ENSMUST00000171619.1
|
Adprhl1
|
ADP-ribosylhydrolase like 1 |
chr18_+_5593566 | 1.13 |
ENSMUST00000160910.1
|
Zeb1
|
zinc finger E-box binding homeobox 1 |
chr14_-_6287250 | 1.13 |
ENSMUST00000170104.2
|
Gm3411
|
predicted gene 3411 |
chr2_-_25319187 | 1.12 |
ENSMUST00000114312.1
|
Grin1
|
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
chr14_-_68124836 | 1.11 |
ENSMUST00000111089.1
ENSMUST00000022638.5 |
Nefm
|
neurofilament, medium polypeptide |
chr7_-_141443314 | 1.10 |
ENSMUST00000106005.2
|
Lrdd
|
leucine-rich and death domain containing |
chr11_+_104576965 | 1.10 |
ENSMUST00000106957.1
|
Myl4
|
myosin, light polypeptide 4 |
chr2_+_107290590 | 1.09 |
ENSMUST00000037012.2
|
Kcna4
|
potassium voltage-gated channel, shaker-related subfamily, member 4 |
chr5_-_66618636 | 1.09 |
ENSMUST00000162382.1
ENSMUST00000160870.1 ENSMUST00000087256.5 ENSMUST00000160103.1 ENSMUST00000162349.1 |
Apbb2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
chr15_+_82256023 | 1.09 |
ENSMUST00000143238.1
|
1500009C09Rik
|
RIKEN cDNA 1500009C09 gene |
chr6_+_17307272 | 1.09 |
ENSMUST00000115454.1
|
Cav1
|
caveolin 1, caveolae protein |
chr1_+_92831614 | 1.08 |
ENSMUST00000045970.6
|
Gpc1
|
glypican 1 |
chr6_-_124863877 | 1.08 |
ENSMUST00000046893.7
|
Gpr162
|
G protein-coupled receptor 162 |
chr17_-_45733843 | 1.07 |
ENSMUST00000178179.1
|
1600014C23Rik
|
RIKEN cDNA 1600014C23 gene |
chr5_+_123076275 | 1.07 |
ENSMUST00000067505.8
ENSMUST00000111619.3 ENSMUST00000160344.1 |
Tmem120b
|
transmembrane protein 120B |
chr6_-_12749193 | 1.06 |
ENSMUST00000046121.6
ENSMUST00000172356.1 |
Thsd7a
|
thrombospondin, type I, domain containing 7A |
chr16_+_10835046 | 1.06 |
ENSMUST00000037913.8
|
Rmi2
|
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
chr11_+_68692070 | 1.06 |
ENSMUST00000108673.1
|
Myh10
|
myosin, heavy polypeptide 10, non-muscle |
chr14_+_30879257 | 1.05 |
ENSMUST00000040715.6
|
Mustn1
|
musculoskeletal, embryonic nuclear protein 1 |
chr7_+_126862431 | 1.04 |
ENSMUST00000132808.1
|
Hirip3
|
HIRA interacting protein 3 |
chr9_-_97018823 | 1.04 |
ENSMUST00000055433.4
|
Spsb4
|
splA/ryanodine receptor domain and SOCS box containing 4 |
chr17_+_56303396 | 1.03 |
ENSMUST00000113038.1
|
Uhrf1
|
ubiquitin-like, containing PHD and RING finger domains, 1 |
chr4_+_99295900 | 1.03 |
ENSMUST00000094955.1
|
Gm12689
|
predicted gene 12689 |
chr19_+_5068077 | 1.03 |
ENSMUST00000070630.6
|
Cd248
|
CD248 antigen, endosialin |
chr11_+_87582201 | 1.03 |
ENSMUST00000133202.1
|
Sept4
|
septin 4 |
chr19_+_7056731 | 1.03 |
ENSMUST00000040261.5
|
Macrod1
|
MACRO domain containing 1 |
chr17_-_48432723 | 1.01 |
ENSMUST00000046549.3
|
Apobec2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
chr4_-_91376490 | 1.00 |
ENSMUST00000107124.3
|
Elavl2
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
chr2_+_49619277 | 1.00 |
ENSMUST00000028102.7
|
Kif5c
|
kinesin family member 5C |
chr1_-_158356258 | 1.00 |
ENSMUST00000004133.8
|
Brinp2
|
bone morphogenic protein/retinoic acid inducible neural-specific 2 |
chr10_+_110745433 | 1.00 |
ENSMUST00000174857.1
ENSMUST00000073781.5 ENSMUST00000173471.1 ENSMUST00000173634.1 |
E2f7
|
E2F transcription factor 7 |
chr2_+_32095518 | 0.99 |
ENSMUST00000057423.5
|
Ppapdc3
|
phosphatidic acid phosphatase type 2 domain containing 3 |
chr10_-_45470201 | 0.99 |
ENSMUST00000079390.6
|
Lin28b
|
lin-28 homolog B (C. elegans) |
chr2_-_118762607 | 0.98 |
ENSMUST00000059997.8
|
A430105I19Rik
|
RIKEN cDNA A430105I19 gene |
chr4_-_130574150 | 0.98 |
ENSMUST00000105993.3
|
Nkain1
|
Na+/K+ transporting ATPase interacting 1 |
chr2_-_127521358 | 0.98 |
ENSMUST00000028850.8
ENSMUST00000103215.4 |
Kcnip3
|
Kv channel interacting protein 3, calsenilin |
chr2_+_58470116 | 0.97 |
ENSMUST00000167423.1
|
Gm17409
|
predicted gene, 17409 |
chr8_+_75109528 | 0.97 |
ENSMUST00000164309.1
|
Mcm5
|
minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) |
chr15_-_76538728 | 0.97 |
ENSMUST00000023219.7
|
Fbxl6
|
F-box and leucine-rich repeat protein 6 |
chr18_-_47333311 | 0.96 |
ENSMUST00000126684.1
ENSMUST00000156422.1 |
Sema6a
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr9_-_107668967 | 0.96 |
ENSMUST00000177567.1
|
Slc38a3
|
solute carrier family 38, member 3 |
chr2_-_156887056 | 0.96 |
ENSMUST00000029164.2
|
Sla2
|
Src-like-adaptor 2 |
chr11_-_77894096 | 0.96 |
ENSMUST00000017597.4
|
Pipox
|
pipecolic acid oxidase |
chr1_+_74791516 | 0.96 |
ENSMUST00000006718.8
|
Wnt10a
|
wingless related MMTV integration site 10a |
chrX_-_36902877 | 0.96 |
ENSMUST00000057093.6
|
Nkrf
|
NF-kappaB repressing factor |
chr5_-_138171813 | 0.95 |
ENSMUST00000155902.1
ENSMUST00000148879.1 |
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chrX_-_48034842 | 0.95 |
ENSMUST00000039026.7
|
Apln
|
apelin |
chr12_+_71170589 | 0.95 |
ENSMUST00000129376.1
|
2700049A03Rik
|
RIKEN cDNA 2700049A03 gene |
chr2_-_5714490 | 0.95 |
ENSMUST00000044009.7
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chrX_-_23266751 | 0.95 |
ENSMUST00000115316.2
|
Klhl13
|
kelch-like 13 |
chr2_-_156887172 | 0.95 |
ENSMUST00000109561.3
|
Sla2
|
Src-like-adaptor 2 |
chr17_-_35702297 | 0.95 |
ENSMUST00000135078.1
|
Ddr1
|
discoidin domain receptor family, member 1 |
chr4_-_156255327 | 0.94 |
ENSMUST00000179919.1
|
Samd11
|
sterile alpha motif domain containing 11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:1990523 | bone regeneration(GO:1990523) |
0.9 | 2.8 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.8 | 5.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 2.3 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.8 | 2.3 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.7 | 2.2 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.7 | 2.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.7 | 2.0 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.6 | 0.6 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.6 | 8.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 1.8 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.6 | 1.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.6 | 2.3 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.5 | 1.5 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.5 | 2.4 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.4 | 5.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 1.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 2.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 2.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 1.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 1.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.4 | 4.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.3 | 2.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 1.0 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.3 | 1.0 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.3 | 1.6 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 0.6 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.3 | 1.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.2 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.3 | 0.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 2.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 5.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 8.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.3 | 2.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.3 | 0.8 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.3 | 0.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.3 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 0.7 | GO:0060032 | notochord regression(GO:0060032) |
0.2 | 1.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 2.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 1.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 1.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.2 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.7 | GO:0019405 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 1.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 2.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.7 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
0.2 | 4.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.2 | 0.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.2 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.9 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.6 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.2 | 0.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 1.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.4 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 2.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 1.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 2.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.2 | 0.6 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 2.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 1.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.7 | GO:0048691 | regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.2 | 0.9 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 1.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.3 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.2 | 1.0 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.2 | 0.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 1.3 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 2.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.2 | 0.5 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.2 | 0.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.5 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 2.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 1.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.6 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 1.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 1.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 3.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.5 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.5 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 1.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.1 | 1.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 2.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.7 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.4 | GO:0015866 | ADP transport(GO:0015866) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 4.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 1.9 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.4 | GO:0061760 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
0.1 | 0.3 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.1 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 1.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.6 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.6 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.1 | 0.3 | GO:2000041 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.3 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 0.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 4.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 2.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 2.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.1 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 1.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 1.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 1.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 1.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 1.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 2.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 1.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 2.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.5 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 0.4 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.7 | GO:0060159 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.2 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.9 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 1.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 1.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.5 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 1.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 1.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 1.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 1.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.0 | 0.5 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.8 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.8 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 1.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.0 | 0.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.4 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 1.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 1.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 1.8 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.1 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 1.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.0 | 0.3 | GO:0010606 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 1.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.0 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 1.8 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 1.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 1.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.8 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.1 | GO:0061215 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) pronephric nephron tubule development(GO:0039020) hepatoblast differentiation(GO:0061017) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) regulation of branch elongation involved in ureteric bud branching(GO:0072095) pronephros morphogenesis(GO:0072114) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.8 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 1.4 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.7 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.4 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 4.0 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.5 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.0 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 1.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.8 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.4 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 1.1 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.0 | 0.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.4 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.3 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.4 | GO:0002718 | regulation of cytokine production involved in immune response(GO:0002718) |
0.0 | 1.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.2 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
0.0 | 0.6 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 1.6 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.7 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.1 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.3 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.2 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 1.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.3 | GO:0007628 | adult walking behavior(GO:0007628) |
0.0 | 0.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 1.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.4 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 9.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.7 | 2.6 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.6 | 2.3 | GO:0044307 | dendritic branch(GO:0044307) |
0.5 | 1.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 2.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 2.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.4 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 1.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 3.9 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 5.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 3.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 1.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 1.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 2.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 9.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 1.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.2 | 1.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.9 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.1 | 1.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 3.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 2.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.2 | GO:0044317 | rod spherule(GO:0044317) |
0.1 | 0.3 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 2.6 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 1.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 1.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 3.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.0 | 1.4 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.8 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 4.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 5.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 5.9 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.6 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 4.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 2.0 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 7.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 2.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.7 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 5.9 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 4.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.9 | 2.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 2.0 | GO:0070540 | stearic acid binding(GO:0070540) |
0.6 | 1.9 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.6 | 1.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 2.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.5 | 5.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.2 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.4 | 2.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 2.3 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.4 | 1.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 2.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 1.0 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.3 | 2.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 3.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 6.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 2.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 1.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.7 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.2 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.6 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.2 | 2.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 9.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 5.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 2.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 4.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 2.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) catalase activity(GO:0004096) |
0.2 | 4.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 2.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 1.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 5.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 4.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.6 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.1 | 0.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 1.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 1.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.1 | 1.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 2.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 0.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 7.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 5.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 1.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 2.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.5 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 4.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 3.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.8 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 2.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 2.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 2.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 3.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 4.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 1.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 1.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 1.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 5.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 3.5 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.9 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.0 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 3.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.5 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 1.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 1.4 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 1.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 1.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.9 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 3.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 4.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 5.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 8.5 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 11.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 5.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 5.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 4.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 1.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 2.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 5.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.3 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 1.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 12.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 10.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 3.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 4.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 4.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.1 | 1.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 5.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 2.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 2.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 1.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.0 | 0.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |